Repository logo
 
Publication

Applications of polymeric and lipid nanoparticles in ophthalmic pharmaceutical formulations: present and future considerations

dc.contributor.authorAlmeida, Hugo
dc.contributor.authorAmaral, Maria Helena
dc.contributor.authorLobão, Paulo
dc.contributor.authorSilva, Ana Catarina
dc.contributor.authorLobo, José Manuel Sousa
dc.date.accessioned2021-04-30T09:06:16Z
dc.date.available2021-04-30T09:06:16Z
dc.date.issued2014
dc.description.abstractThe unique properties and characteristics of ocular tissues and the whole set of defence mechanisms of the ocular globe make the instillation of ocular drugs into a difficult task with a low rate of therapeutic response. One of the challenges for the new generation of ophthalmic pharmaceutical formulations is to increase the bioavailability of drugs administered by the ocular route and, therefore, their therapeutic efficacy. This can be achieved with the use of some strategies that provide an increase in the formulation pre-corneal residence time, mucoadhesion and penetration across the eye tissues. Colloidal carrier systems have been very successfully used for the selective and targeted delivery of drugs for several routes of administration. In this context, nanoparticles prepared with specific polymers or lipids and coated, dispersed or suspended in polymer solutions with mucoadhesion properties or in situ gelling properties will be an excellent strategy that deserves attention and further research. In this review, the characteristics and main properties of polymeric and lipid nanoparticles are discussed and examples and advantages of the application of these colloidal carrier systems for the ophthalmic administration of drugs are presented. The future directions of the research required in this specific field are also presented.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.doi10.18433/J3DP43pt_PT
dc.identifier.issn1482-1826
dc.identifier.urihttp://hdl.handle.net/10284/9838
dc.language.isoengpt_PT
dc.publisherCanadian Society for Pharmaceutical Sciencespt_PT
dc.titleApplications of polymeric and lipid nanoparticles in ophthalmic pharmaceutical formulations: present and future considerationspt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.citation.endPage293pt_PT
oaire.citation.issue3pt_PT
oaire.citation.startPage278pt_PT
oaire.citation.titleJournal of Pharmacy & Pharmaceutical Sciencespt_PT
oaire.citation.volume17pt_PT
person.familyNameSilva
person.givenNameAna Catarina
person.identifier953153
person.identifier.ciencia-id5C1D-ED22-0D64
person.identifier.orcid0000-0001-6923-0232
person.identifier.ridF-1875-2017
person.identifier.scopus-author-id57028697500
rcaap.rightsrestrictedAccesspt_PT
rcaap.typearticlept_PT
relation.isAuthorOfPublication67e7f707-32ec-444a-a20d-a17f8e6e7c21
relation.isAuthorOfPublication.latestForDiscovery67e7f707-32ec-444a-a20d-a17f8e6e7c21

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Applications of Polymeric and Lipid Nanoparticles in Ophthalmic Pharmaceutical Formulations Present and Future Considerations.pdf
Size:
448.97 KB
Format:
Adobe Portable Document Format